Vascular smooth muscle cells efficiently activate a new proteinase cascade involving plasminogen and fibronectin

被引:24
作者
Houard, X
Monnot, C
Dive, V
Corvol, P
Pagano, M
机构
[1] Coll France, INSERM, U36, F-75231 Paris 05, France
[2] CEA, CE Saclay, Dept Etud & Ingn Prot, F-91191 Gif Sur Yvette, France
关键词
vascular smooth muscle cells; plasminogen; fibronectin; Fn-proteinase;
D O I
10.1002/jcb.10460
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The plasminogen/plasmin system is involved in vascular wall remodeling after injury, through extracellular matrix (ECM) degradation and proteinase activation. Vascular smooth muscle cells (VSMCs) synthesize various components of the plasminogen/plasmin system. We investigated the conversion of plasminogen into plasmin in primary cultured rat VSMCs. VSMCs efficiently converted exogenous plasminogen into plasmin in a time- and dose-dependent manner. We measured plasmin activity by monitoring the hydrolysis of Tosyl-G-P-R-Mca, a fluorogenic substrate of plasmin. Cell-mediated plasmin activation was associated with the degradation of ECM, as revealed by fibronectin proteolysis. Plasmin also activated a proteinase able to hydrolyze Mca-P-L-G-L-Dpa-A-R-NH2, a fluorogenic substrate of matrix metalloproteinases (MMPs). However, this proteinase was not inhibited by an MMP inhibitor. Furthermore, this proteinase displayed similar biochemical and pharmacological properties to fibronectin-proteinase, a recently identified zinc-dependent metal loproteinase located in the gelatin-binding domain of fibronectin. These results show that VSMCs convert exogenous plasminogen into plasmin in their pericellular environment. By hydrolyzing matrix protein plasmin activates a latent metal loproteinase that differs from MMP, fibronectin-proteinase. This metal loproteinase may participate to vascular wall remodeling, in concert with other proteinases. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:1188 / 1201
页数:14
相关论文
共 47 条
[1]   Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model [J].
Allaire, E ;
Forough, R ;
Clowes, W ;
Starcher, B ;
Clowes, AW .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) :1413-1420
[2]   Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation [J].
Baramova, EN ;
Bajou, K ;
Remacle, A ;
LHoir, C ;
Krell, HW ;
Weidle, UH ;
Noel, A ;
Foidart, JM .
FEBS LETTERS, 1997, 405 (02) :157-162
[3]   SELECTIVE ISOLATION OF RAT AORTIC-WALL LAYERS AND THEIR CELL-TYPES IN CULTURE - APPLICATION TO CONVERTING-ENZYME ACTIVITY MEASUREMENT [J].
BATTLE, T ;
ARNAL, JF ;
CHALLAH, M ;
MICHEL, JB .
TISSUE & CELL, 1994, 26 (06) :943-955
[4]   REGULATION OF CORNEAL FIBROBLAST MMP-1 COLLAGENASE SECRETION BY PLASMIN [J].
BERMAN, MB .
CORNEA, 1993, 12 (05) :420-432
[5]   Expression of collagenase/gelatinase activity from basement-membrane fibronectin - Isolation after limited proteolysis of a bovine lens capsule and molecular definition of this thiol-dependent zinc metalloproteinase [J].
Boudjennah, L ;
Dalet-Fumeron, V ;
Pagano, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 255 (01) :246-254
[6]   Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase and coagulation system [J].
Carmeliet, P ;
Collen, D .
THROMBOSIS RESEARCH, 1998, 91 (06) :255-285
[7]   Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation [J].
Carmeliet, P ;
Moons, L ;
Lijnen, HR ;
Baes, M ;
Lemaitre, V ;
Tipping, P ;
Drew, A ;
Eeckhout, Y ;
Shapiro, S ;
Lupu, F ;
Collen, D .
NATURE GENETICS, 1997, 17 (04) :439-444
[8]  
Chevalier X, 1996, BRIT J RHEUMATOL, V35, P506
[9]   SMOOTH-MUSCLE CELLS EXPRESS UROKINASE DURING MITOGENESIS AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR DURING MIGRATION IN INJURED RAT CAROTID-ARTERY [J].
CLOWES, AW ;
CLOWES, MM ;
AU, YPT ;
REIDY, MA ;
BELIN, D .
CIRCULATION RESEARCH, 1990, 67 (01) :61-67